The effectiveness and side effects of Gabapentin, a medication used to treat certain types of nerve pain and seizures, can be influenced by several genetic factors. These genetic influences can affect how an individual's body processes the medication, how much of the medication is needed for it to be effective, and what side effects the individual might experience. Understanding these genetic influences can help healthcare providers tailor treatment plans to individual patients, potentially improving outcomes and reducing side effects.
- CYP2C19 gene: This gene plays a role in how the body metabolizes Gabapentin. Variations can affect how quickly the body breaks down and removes the medication. This can influence the dosage needed and the risk of side effects. 
- ABCB1 gene: This gene can influence how Gabapentin is transported within the body. Certain genetic variations can affect how much of the medication reaches the brain, which can impact its effectiveness and the risk of side effects. 
- SLC22A1 gene: This gene can affect how Gabapentin is absorbed in the intestines and eliminated by the kidneys. Variations in this gene can influence the amount of medication that stays in the body, which can affect both its effectiveness and potential side effects. 
rs4240803
Génotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Résumé
Individuals with the genotype A/A have decreased Drug Effect and increased Dosage to GABAPENTIN.
Niveau de preuve
Plus d'infos
Génotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Résumé
Individuals with the genotype A/G have decreased Drug Effect, increased Dosage and increased Side Effects to GABAPENTIN.
Niveau de preuve
Plus d'infos
Génotype
Impacts
Breakdown
Drug Effect
Side Effects
Dosage
Résumé
Individuals with the genotype G/G have decreased Drug Effect, decreased Dosage and decreased Side Effects to GABAPENTIN.
Niveau de preuve
Plus d'infos
Légende:
Augmenté
Diminué
Aucun effet connu
rs4240803
Génotype
Niveau de preuve
Effet
Résumé
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/A have decreased Drug Effect and increased Dosage to GABAPENTIN.
plus d'infos
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype A/G have decreased Drug Effect, increased Dosage and increased Side Effects to GABAPENTIN.
plus d'infos
Breakdown
Drug Effect
Side Effects
Dosage
Individuals with the genotype G/G have decreased Drug Effect, decreased Dosage and decreased Side Effects to GABAPENTIN.
plus d'infos
Légende:
Augmenté
Diminué
Aucun effet connu
Il est essentiel que les prestataires de soins de santé tiennent compte des facteurs individuels des patients et comprennent leurs profils génétiques spécifiques pour prendre des décisions de traitement personnalisées avec GABAPENTIN.